Intuitive Surgical Stock (NYSE:ISRG) Mid-Year Review: More Gains Are Likely
Intuitive Surgical outperformed in Q2 2024, with revenue growth of 13.6% and impressive gains in all segments. The success of the da Vinci 5 system and the "razor and blades" model drove profitability, despite valuation concerns.